Abstract
Various mechanisms including polyol pathway along with a complex integrating paradigm with oxidative stress and advanced glycation end products (AGE) formation have been implicated in the pathogenesis of diabetic nephropathy. The present study was aimed at investigating a well known antioxidant, pterostilbene for its therapeutic role in streptozotocin-induced diabetic nephropathy in rats. The effect of pterostilbene was investigated by assessing the key markers of kidney function along with the morphological changes in the kidney. Further, the effect of pterostilbene on the formation of AGEs, aldose reductase (AR) inhibition and lipid peroxidation was compared with that of a standard AR inhibitor, fidarestat. The results revealed that pterostilbene significantly decreased the blood glucose levels, urinary protein excretion, serum creatinine and blood urea nitrogen in diabetic rats. Administration of pterostilbene to diabetic rats decreased kidney lipid peroxides and nitrate levels along with decrease in AGEs formation. In addition, pterostilbene was found to inhibit kidney AR activity with a decrease in serum TGF β levels. Thus, the results obtained in this study underline the potential of pterostilbene as a possible therapeutic agent against diabetic complications such as nephropathy.
Similar content being viewed by others
References
Amarnath Satheesh M, Pari L (2006) The antioxidant role of pterostilbene in streptozotocin-nicotinamide-induced type 2 diabetes mellitus in wistar rats. J Pharm Pharmacol 58(11):1483–1490
Aurell M, Björck S (1992) Determinants of progressive renal disease in diabetes mellitus. Kidney Int Suppl 36:S38–S42
Baig MA, Gawali VB, Patil RR, Naik SR (2012) Protective effect of herbomineral formulation (dolabi) on early diabetic nephropathy in streptozotocin-induced diabetic rats. J Nat Med 66:500–509
Baynes JW, Thorpe SR (1999) Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48:1–9
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820
Chakraborty A, Gupta N, Ghosh K, Roy P (2010) In vitro evaluation of the cytotoxic, anti-proliferative and anti-oxidant properties of pterostilbene isolated from Pterocarpus marsupium. Toxicol in Vitro 24(4):1215–1228
Dronavalli S, Duka I, Bakris GL (2008) The pathogenesis of diabetic nephropathy. Nat Clin Pract Endocrinol Metab 4:444–452
Forbes JM, Cooper ME, Oldfield MD, Thomas MC (2003) Role of advanced glycation end products in diabetic nephropathy. J Am Soc Nephrol 14:S254–S258
Forbes JM, Fukami K, Cooper ME (2007) Diabetic nephropathy: where hemodynamics meets metabolism. Exp Clin Endocrinol. Diabetes 115:69–84
Hervey GR (1953) Determination of creatinine by Jaffe reaction. Nature 171:1125
Huggett AS, Nixon DA (1957) Use of glucose oxidase, peroxidase, and O-dianisidine in determination of blood and urinary glucose. Lancet 273:368–370
Jennings PE, Nightingale S, Le Guen C, Lawson N, Williamson JR, Hoffman P, Barnett AH (1990) Prolonged aldose reductase inhibition in chronic peripheral diabetic neuropathy: effects on microangiopathy. Diabet Med 7:63–68
Jiang WL, Zhang SP, Hou J, Zhu HB (2012) Effect of loganin on experimental diabetic nephropathy. Phytomedicine 19:217–222
Kim HY, Oh JH (1999) Screening of Korean forest plants for rat lens aldose reductase inhibition. Biosci Biotechnol Biochem 63:184–188
Lewis EJ, Hunsicker LG, Bain RP, Rohde RD (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group N Engl J Med 329:1456–1462
Lv L, Shao X, Wang L, Huang D, Ho CT, Sang S (2010) Stilbene glucoside from Polygonum multiflorum thunb.: a novel natural inhibitor of advanced glycation end product formation by trapping of methylglyoxal. J Agric Food Chem 58(4):2239–2245
Maack T, Johnson V, Kau ST, Figueiredo J, Sigulem D (1979) Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review. Kidney Int 16:251–270
McCormack D, McFadden D (2013) A review of pterostilbene antioxidant activity and disease modification. Oxidative Med Cell Longev. doi:10.1155/2013/575482
Miranda K, Espy MG, Wink DA (2001) A rapid and simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5:62–71
Nishibayashi S, Hattori K, Hirano T, Uehara K, Nakano Y, Aihara M, Yamada Y, Muraguchi M, Iwata F, Takiguchi Y (2010) Functional and structural changes in end-stage kidney disease due to glomerulonephritis induced by the recombinant alpha3(IV)NC1 domain. Exp Anim 59:157–170
Oates PJ, Mylari BL (1999) Aldose reductase inhibitors: therapeutic implications for diabetic complications. Expert Opin Investig Drugs 8:2095–2119
Packham DK, Alves TP, Dwyer JP, Atkins R, de Zeeuw D, Cooper M, Shahinfar S, Lewis JB, Lambers Heerspink HJ (2012) Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (diabetes mellitus treatment for renal insufficiency consortium) database. Am J Kidney Dis 59:75–83
Pitocco D, Zaccardi F, Di SE, Romitelli F, Santini SA, Zuppi C, Ghirlanda G (2010) Oxidative stress, nitric oxide, and diabetes. Rev Diabet Stud 7:15–25
Qi S, Wu D (2013) Bone marrow-derived mesenchymal stem cells protect against cisplatin-induced acute kidney injury in rats by inhibiting cell apoptosis. Int J Mol Med 32(6):1262–1272
Rossing P (2006) Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history. Curr Diab Rep 6:479–683
Rudberg S, Persson B, Dahlquist G (1992) Increased glomerular filtration rate as a predictor of diabetic nephropathy–an 8-year prospective study. Kidney Int 41:822–828
Sensi M, Pricci F, Pugliese G, De Rossi MG, Petrucci AF, Cristina A, Morano S, Pozzessere G, Valle E, Andreani D, et al. (1996) Role of advanced glycation end-products (AGE) in late diabetic complications. Diabetes Res Clin Pract 28:9–17
Utley HG, Frederick B, Paul H (1967) Effect of sulfhydryl reagents on peroxidation in microsomes. Arch Biochem Biophys 118:29–32
Veeresham C, Rama Rao A, Asres K (2014) Aldose reductase inhibitors of plant origin. Phytother Res 28:317–333
Wybenga DR, Di GJ, Pileggi VJ (1971) Manual and automated methods for urea nitrogen measurement in whole serum. Clin Chem 17:891–895
Acknowledgments
The authors are thankful to University Grants Commission, Government of India for the financial support in the form of UGC-BSR fellowship to one of the authors. Symed Labs Ltd. (Hyderabad, India) is gratefully acknowledged for the generous gift of fidarestat sample.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical Statement
The experimental protocol was approved by the Institutional Animal Ethics Committee (No.IAEC 2/UCPSC/KU/2014) and executed in agreement with the guiding principles of Committee for Control and Supervision of Experimentation on Animals, Government of India on animal experimentation.
Conflict of Interest
The authors have no conflict of interest in any form.
Rights and permissions
About this article
Cite this article
Dodda, D., Ciddi, V. Pterostilbene alleviates diabetic nephropathy in experimental diabetic rats; inhibition of aldose reductase and advanced glycation end products formation. Orient Pharm Exp Med 15, 297–303 (2015). https://doi.org/10.1007/s13596-015-0204-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13596-015-0204-8